Leanna Cheung

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Christopher J. Sweeney, Andrew Martin, Martin R. Stockler et al. · The Lancet Oncology · 2023 · 175 citations

Urology, Oncology, Genitourinary Cancer +7

Notch-1 activates estrogen receptor-α-dependent transcription via IKKα in breast cancer cells

Liang Hao, Paola Rizzo, Clodia Osipo et al. · Oncogene · 2009 · 124 citations · Full text

Transcriptional Regulation, Signal Transduction, Signaling Pathway +13

High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)

Leanna Cheung, Claudia L. Flemming, Fujiko Watt et al. · Biochemical Pharmacology · 2014 · 69 citations · Full text

Drug Target, Ceefourin 2, Biochemistry +10

Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen

Leanna Cheung, Denise Yu, Zillan Neiron et al. · Biochemical Pharmacology · 2014 · 33 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +8

Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia

Klaartje Somers, Kathryn Evans, Leanna Cheung et al. · Leukemia · 2019 · 30 citations · Full text

Hematological Malignancy, Tumor Biology, Novel Therapy +10